Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Colon & Rectum (Late Stage^), 2017-2021

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Count

State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count ascending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 21.8 (21.8, 21.9) N/A 83,825 59.8
California 3 19.3 (19.1, 19.4) 43 (39, 47) 8,438 57.2
Texas 3 23.0 (22.7, 23.2) 16 (13, 21) 6,767 60.8
Florida 6 21.7 (21.4, 21.9) 27 (22, 30) 6,397 59.9
New York 3 20.4 (20.2, 20.7) 36 (32, 40) 5,022 57.0
Pennsylvania 6 23.4 (23.0, 23.7) 14 (10, 19) 3,956 62.4
Illinois 3 23.8 (23.4, 24.1) 11 (7, 15) 3,627 61.2
Ohio 6 23.9 (23.5, 24.3) 10 (7, 14) 3,496 61.3
North Carolina 6 22.1 (21.7, 22.5) 24 (18, 28) 2,734 62.2
Georgia 3 22.9 (22.5, 23.3) 17 (12, 22) 2,692 58.3
Michigan 6 21.3 (20.9, 21.7) 29 (24, 34) 2,665 60.1
New Jersey 3 21.8 (21.4, 22.2) 26 (20, 30) 2,489 57.6
Virginia 6 20.0 (19.6, 20.4) 38 (33, 43) 2,012 59.1
Tennessee 6 23.8 (23.3, 24.3) 12 (7, 17) 1,964 61.4
Missouri 6 24.5 (24.0, 25.1) 8 (5, 12) 1,845 62.8
Washington 5 21.0 (20.5, 21.4) 32 (27, 37) 1,814 61.2
Arizona 6 19.0 (18.6, 19.4) 46 (40, 48) 1,640 59.2
Wisconsin 6 21.3 (20.8, 21.8) 30 (23, 35) 1,540 61.3
Maryland 6 21.0 (20.5, 21.5) 31 (26, 37) 1,530 59.6
Kentucky 3 26.2 (25.6, 26.9) 3 (2, 6) 1,427 57.1
Louisiana 3 25.8 (25.2, 26.5) 4 (2, 7) 1,402 57.9
South Carolina 6 22.0 (21.5, 22.5) 25 (18, 30) 1,392 61.4
Minnesota 6 20.7 (20.2, 21.2) 34 (28, 40) 1,377 57.1
Alabama 6 22.1 (21.6, 22.7) 23 (17, 30) 1,361 54.8
Colorado 6 19.5 (19.0, 20.0) 41 (36, 48) 1,216 62.2
Oklahoma 6 23.0 (22.4, 23.7) 15 (9, 24) 1,044 56.9
Oregon 6 20.1 (19.5, 20.7) 37 (31, 44) 1,036 61.4
Mississippi 6 29.0 (28.2, 29.8) 1 (1, 1) 1,024 62.0
Arkansas 6 25.1 (24.3, 25.8) 6 (3, 10) 920 60.7
Iowa 3 22.8 (22.1, 23.5) 18 (10, 27) 884 56.6
Connecticut 3 19.0 (18.5, 19.6) 45 (38, 48) 864 56.0
Kansas 6 23.8 (23.0, 24.5) 13 (6, 20) 803 60.6
Puerto Rico 6 18.4 (17.8, 19.0) N/A 767 49.2
Nevada 6 19.2 (18.6, 19.9) 44 (37, 48) 688 56.5
West Virginia 6 26.7 (25.7, 27.6) 2 (2, 6) 657 59.8
Nebraska 6 22.7 (21.8, 23.7) 19 (9, 29) 509 57.8
Utah 3 17.3 (16.7, 18.1) 50 (47, 50) 491 59.2
New Mexico 3 18.9 (18.1, 19.7) 47 (38, 49) 484 57.2
Idaho 3 22.1 (21.2, 23.1) 22 (13, 34) 454 62.5
Hawaii 3 22.1 (21.2, 23.2) 21 (12, 34) 409 57.9
Maine 6 20.5 (19.6, 21.5) 35 (24, 45) 393 58.5
New Hampshire 6 20.7 (19.8, 21.8) 33 (21, 44) 374 60.9
Montana 6 22.5 (21.3, 23.7) 20 (9, 34) 309 61.0
Rhode Island 6 19.7 (18.6, 20.8) 40 (30, 48) 271 60.3
South Dakota 6 25.0 (23.6, 26.4) 7 (2, 18) 264 63.3
Delaware 6 19.9 (18.8, 21.1) 39 (27, 48) 256 59.3
North Dakota 6 24.0 (22.5, 25.6) 9 (3, 26) 208 61.7
Alaska 6 25.2 (23.5, 27.0) 5 (2, 18) 184 60.8
Vermont 6 18.6 (17.3, 20.1) 48 (33, 50) 160 56.8
Wyoming 6 21.6 (20.0, 23.3) 28 (9, 44) 149 60.9
District of Columbia 6 19.3 (17.8, 20.9) 42 (27, 50) 127 53.7
Indiana 6
data not available
N/A
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 12/07/2024 11:19 pm.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Data not available for this combination of data selections.
1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2023 submission.
3 Source: SEER November 2023 submission. State Cancer Registry also receives funding from CDC's National Program of Cancer Registries.
5 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2023 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2023 submission).

Data for the United States does not include data from Indiana.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top